Oppenheimer & Co’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$511K Buy
10,611
+54
+0.5% +$2.52K 0.01% 1182
2025
Q4
$512K Sell
10,557
-375
-3% -$18.6K 0.01% 1068
2025
Q3
$516K Buy
10,932
+1,963
+22% +$94.7K 0.01% 1159
2025
Q2
$433K Buy
8,969
+329
+4% +$16.8K 0.01% 1194
2025
Q1
$479K Buy
8,640
+298
+4% +$16.1K 0.01% 1089
2024
Q4
$402K Buy
8,342
+25
+0.3% +$1.27K 0.01% 1152
2024
Q3
$479K Sell
8,317
-53
-0.6% -$2.86K 0.01% 1045
2024
Q2
$406K Sell
8,370
-90
-1% -$4.34K 0.01% 1075
2024
Q1
$411K Sell
8,460
-9
-0.1% -$439 0.01% 1065
2023
Q4
$421K Sell
8,469
-1,509
-15% -$73.8K 0.01% 1021
2023
Q3
$535K Sell
9,978
-397
-4% -$21.2K 0.01% 919
2023
Q2
$559K Buy
10,375
+200
+2% +$10.8K 0.01% 927
2023
Q1
$554K Sell
10,175
-127
-1% -$6.18K 0.01% 902
2022
Q4
$499K Buy
10,302
+53
+0.5% +$2.33K 0.01% 906
2022
Q3
$390K Sell
10,249
-845
-8% -$37.7K 0.01% 984
2022
Q2
$555K Buy
11,094
+248
+2% +$13.2K 0.01% 881
2022
Q1
$557K Buy
10,846
+10
+0.1% +$516 0.01% 966
2021
Q4
$543K Buy
10,836
+147
+1% +$7.27K 0.01% 1004
2021
Q3
$515K Buy
10,689
+5
+0% +$254 0.01% 1010
2021
Q2
$563K Sell
10,684
-821
-7% -$42.8K 0.01% 972
2021
Q1
$568K Sell
11,505
-1,529
-12% -$73.5K 0.01% 913
2020
Q4
$634K Sell
13,034
-18,379
-59% -$906K 0.01% 803
2020
Q3
$1.58M Sell
31,413
-10,603
-25% -$546K 0.04% 444
2020
Q2
$2.15M Buy
42,016
+10,208
+32% +$496K 0.06% 364
2020
Q1
$1.39M Sell
31,808
-1,192
-4% -$57K 0.04% 431
2019
Q4
$1.66M Buy
33,000
+142
+0.4% +$6.65K 0.04% 462
2019
Q3
$1.52M Buy
32,858
+21,638
+193% +$933K 0.04% 475
2019
Q2
$485K Sell
11,220
-2,583
-19% -$110K 0.01% 828
2019
Q1
$611K Sell
13,803
-1,030
-7% -$44.1K 0.02% 734
2018
Q4
$645K Sell
14,833
-219
-1% -$9.66K 0.02% 661
2018
Q3
$672K Sell
15,052
-288
-2% -$12.3K 0.02% 740
2018
Q2
$614K Sell
15,340
-1,077
-7% -$42.4K 0.02% 779
2018
Q1
$658K Sell
16,417
-1,144
-7% -$47.6K 0.02% 757
2017
Q4
$756K Sell
17,561
-2,398
-12% -$111K 0.02% 710
2017
Q3
$994K Sell
19,959
-633
-3% -$30.6K 0.03% 614
2017
Q2
$986K Sell
20,592
-3,798
-16% -$182K 0.03% 605
2017
Q1
$1.1M Sell
24,390
-2,366
-9% -$100K 0.03% 545
2016
Q4
$1.08M Buy
26,756
+3,604
+16% +$142K 0.03% 532
2016
Q3
$884K Sell
23,152
-2,965
-11% -$119K 0.03% 614
2016
Q2
$1.09M Sell
26,117
-420
-2% -$17.2K 0.03% 535
2016
Q1
$1.06M Sell
26,537
-16,111
-38% -$647K 0.03% 521
2015
Q4
$1.82M Sell
42,648
-5,674
-12% -$261K 0.05% 376
2015
Q3
$2.29M Buy
48,322
+2,641
+6% +$134K 0.07% 326
2015
Q2
$2.26M Sell
45,681
-7,120
-13% -$361K 0.06% 355
2015
Q1
$2.61M Buy
52,801
+9,659
+22% +$462K 0.07% 320
2014
Q4
$1.97M Buy
43,142
+18,175
+73% +$882K 0.06% 389
2014
Q3
$1.41M Buy
24,967
+1,507
+6% +$80.9K 0.04% 488
2014
Q2
$1.25M Sell
23,460
-3,166
-12% -$168K 0.04% 535
2014
Q1
$1.39M Buy
26,626
+7,233
+37% +$366K 0.04% 485
2013
Q4
$1.04M Sell
19,393
-3,938
-17% -$203K 0.03% 546
2013
Q3
$1.18M Sell
23,331
-5,910
-20% -$301K 0.04% 476
2013
Q2
$1.51M Buy
+29,241
New +$1.56M 0.06% 377

Other funds holding SNY

Oppenheimer & Co's SNY Position: Q1 2026 in Review

Oppenheimer & Co increased its Sanofi (SNY) stake by 0.51% in Q1 2026, buying an estimated $2.52K and bringing the position to 10,611 shares worth $511K. The position accounts for 0.01% of the portfolio, ranked #1182.

Oppenheimer & Co first reported a position in SNY in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.61M in Q1 2015. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

  • Oppenheimer & Co held 10,611 shares of Sanofi worth $511K as of Q1 2026.
  • Oppenheimer & Co bought 54 Sanofi shares in Q1 2026, an estimated $2.52K.
  • Sanofi made up 0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1182 holding.
  • Oppenheimer & Co first reported a position in Sanofi in Q2 2013 and has held it in 52 quarters since.
  • Oppenheimer & Co's Sanofi position peaked at $2.61M in Q1 2015.
  • 737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.